Clinical Trials Directory

Trials / Completed

CompletedNCT03118245

Ambu AuraGain Laryngeal Mask Airway and I-gel in Children

A Randomized Comparison of Ambu AuraGain (Original Name of Product) Laryngeal Mask Airway and I-gel in Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
94 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
7 Years
Healthy volunteers
Accepted

Summary

Children aged below 7 years are randomly assigned to AuraGain Group or I-gel group. After anesthetic induction, AuraGain or I-gel is inserted and mechanical ventilation is started. Oropharyngeal leak pressure, peak inspiratory pressure, success rate for insertion, ease for insertion, ease for gastric tube insertion and fiberoptic bronchoscopic views will be compared between two groups.

Conditions

Interventions

TypeNameDescription
DEVICEAuraGainAfter anesthetic induction, AuraGain is inserted in children
DEVICEI-gelAfter anesthetic induction, I-gel is inserted in children

Timeline

Start date
2017-06-12
Primary completion
2018-05-31
Completion
2018-05-31
First posted
2017-04-18
Last updated
2018-09-06

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03118245. Inclusion in this directory is not an endorsement.

Ambu AuraGain Laryngeal Mask Airway and I-gel in Children (NCT03118245) · Clinical Trials Directory